A bifunctional actuator to correct loss-of-function deficits in cardiac voltage-gated sodium channels
Science Advances · 2026
DOI: 10.1126/sciadv.aeb2110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Lucile Fossier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Myocytes, Cardiac. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Despite their emerging prominence, ion channelopathies have remained challenging to correct, as ion channel dysfunction linked to disease is multifaceted, involving changes in activity and/or localization. Yet, current corrective strategies typically focus on restoring only one aspect leading to incomplete efficacy. Here, focusing on the voltage-gated sodium channel, Na V 1.5, whose dysfunction is linked to life-threatening cardiac arrhythmias, we develop a genetically encoded bifunctional actuator as a proof-of-concept molecular strategy to reverse pathophysiological changes in channel function. Specifically, we engineer a high affinity nanobody targeting Na V 1.5 with two moieties: (i) a peptide that restores proper inactivation and (ii) a linkage-specific deubiquitinase that promotes surface-membrane localization. Functional validation in heterologous systems and in human and mouse cardiomyocytes demonstrated restoration of Na V 1.5 trafficking and/or gating. In all, this approach shows promise for reversing molecular deficits observed with Na V channelopathies and provides a framework to engineer multifunctional modulators targeting ion channelopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032, USA.
- Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
- Discovery Chemistry, Merck Research Laboratory, Merck and Co. Inc., West Point, PA 19486, USA.
- Department of Medicine, Columbia University, New York, NY 10032, USA.
- College of Dental Medicine, Columbia University, New York, NY 10032, USA.
- Department of Pharmacology and Molecular Therapeutics, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Lucile Fossier, Marc Yehya, Richard Z Zhuang, Sri Karthika Shanmugam, Ryan Mahling, Timothy Cho, Audrey Kochiss, Allen L Hsu, Sandra B Gabelli, Gordana Vunjak-Novakovic, Henry M Colecraft, Manu Ben-Johny
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIBIB NIH HHS
- National Heart, Lung, and Blood Institute
- American Heart Association
Zitieren
APA
Fossier, L., Yehya, M., Zhuang, R. Z., Shanmugam, S. K., Mahling, R., Cho, T., Kochiss, A., Hsu, A. L., Gabelli, S. B., Vunjak-Novakovic, G., Colecraft, H. M., & Ben-Johny, M. (2026). A bifunctional actuator to correct loss-of-function deficits in cardiac voltage-gated sodium channels. Science Advances. https://doi.org/10.1126/sciadv.aeb2110
Vancouver
Fossier L, Yehya M, Zhuang RZ, Shanmugam SK, Mahling R, Cho T, et al. A bifunctional actuator to correct loss-of-function deficits in cardiac voltage-gated sodium channels. Science Advances. 2026. doi:10.1126/sciadv.aeb2110
BibTeX
@article{Fossier2026,
author = {Fossier, Lucile and Yehya, Marc and Zhuang, Richard Z and Shanmugam, Sri Karthika and Mahling, Ryan and Cho, Timothy and Kochiss, Audrey and Hsu, Allen L and Gabelli, Sandra B and Vunjak-Novakovic, Gordana and Colecraft, Henry M and Ben-Johny, Manu},
title = {A bifunctional actuator to correct loss-of-function deficits in cardiac voltage-gated sodium channels},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aeb2110}
}
EUVIMED